Diplomat Pharmacy (DPLO) Misses Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Mizuho Securities Remains Sidelined on Diplomat Pharmacy (DPLO) Following 4Q
March 1, 2017 2:17 PM ESTMizuho Securities reiterated a Neutral rating and $17.00 price target on Diplomat Pharmacy (NYSE: DPLO) following the company's 4Q earnings report.
Analyst Ann Hynes commented, "We are reiterating our price target of $17 while lowering our 2017E and 2018E adjusted EPS to $0.62 and $0.75, respectively. We think... More
